The effect of intracoronary fibroblast growth factor‐2 on restenosis after primary angioplasty or stent placement in a pig model of atherosclerosis

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Cardiology

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/CLC.4960250606PMID 12058790PMCID PMC6653872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and Angiographic Characteristics of 236 Coronary Segments Treated by Coronary Atherectomy or Stenting Patients

  2005cited by this paper
• Coronary Artery Disease: Vascular Endothelial Growth Factor and Fibroblast Growth Factor.

  2001cited by this paper
• Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

  2000cited by this paper
• Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease

  2000cited by this paper
• Effect of a single bolus of intracoronary basic fibroblast growth factor on perfusion in an ischemic porcine model.

  1999cited by this paper
• Angiogenesis and cardiovascular disease

  1999cited by this paper
• Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

  1999cited by this paper
• Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia.

  1998cited by this paper
• The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling.

  1998cited by this paper
• The relation between de novo atherosclerosis remodeling and angioplasty-induced remodeling in an atherosclerotic Yucatan micropig model.

  1998cited by this paper
• Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

  1998cited by this paper
• Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury.

  1997cited by this paper
• Basic FGF regulates interstitial collagenase gene expression in human smooth muscle cells.

  1997cited by this paper
• Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor.

  1997cited by this paper
• Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model.

  1997cited by this paper
• Angiogenesis in ischemic heart disease

  1997cited by this paper
• Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters.

  1997cited by this paper
• Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart

  1996cited by this paper
• Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.

  1996cited by this paper
• Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft.

  1996cited by this paper
• Vascular endothelial growth factor administration in chronic myocardial ischemia.

  1996cited by this paper
• VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.

  1996cited by this paper
• Effects of a single administration of fibroblast growth factor on vascular wall reaction to injury.

  1995cited by this paper
• The Intima: Soil for Atherosclerosis and Restenosis

  1995influential reference
• Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance.

  1995cited by this paper
• Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

  1994cited by this paper
• The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig.

  1994cited by this paper
• Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study.

  1993influential reference
• The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting

  1992cited by this paper
• Acidic fibroblast growth factor promotes vascular repair.

  1991cited by this paper
• Effects of acidic fibroblast growth factor on normal and ischemic myocardium.

  1991cited by this paper
• Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions.

  1990cited by this paper
• Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries.

  1990cited by this paper
• Yucatan miniature swine as a model for diet-induced atherosclerosis.

  1982cited by this paper
• Basic Fibroblast Growth Factor Stimulates Endothelial Regrowth and Proliferation in Denuded Arteries

  year unknowncited by this paper

• Beyond Growth Factors: Macrophage-Centric Strategies for Angiogenesis

  2020cites this paper
• Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients.

  2018cites this paper
• 6-Month Follow-Up of a Novel Biodegradable Drug-Eluting Stent Composed of Poly-L-Lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery.

  2015cites this paper
• Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease.

  2014cites this paper
• Controlled release of angiogenic growth factors from poly(lactic -co -glycolic acid) implants for therapeutic angiogenesis

  2009cites this paper
• Gene Deletion of NF-κB p105 Enhances Neointima Formation in a Mouse Model of Carotid Artery Injury

  2006cites this paper
• Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal

  2005cites this paper
• Angiogenic Factors in Human Atherosclerotic Lesions and Relationship to Intraplaque Angiogenesis

  2005cites this paper
• Angiogenesis: where do we stand now?

  2005cites this paper
• Update on therapeutic neovascularization.

  2005cites this paper
• The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.

  2003cites this paper